26 y 27 marzo 2021 evento virtual
TRANSCRIPT
26 Y 27 MARZO 2021EVENTO VIRTUAL
Celebramos la 5ª edición de el eventomás relevante de Radio Oncología en
Norteamerica ahora en México
PROGRAMAPRELIMINAR
WhatsApp: 999 549 7809
COMITÉ CIENTÍFICO
PROFESORES
Dra. Julia Saenz Dra. Nimbe Barroso
Dra. Christian Haydee Flores Balcázar Dra. Karla Elizabeth Ramirez Alday Dra. Lorena Lio Mondragón Dra. Sandra Ileana Pérez ÁlvarezDra. Nimbe BarrosoDr. Onix Garay VillarDr. Alejandro Solórzano MeléndezDra. Adriana Jimenez Cantero Dr. Luis Héctor Bayardo López Dr. Pedro Rubén León Arceo Dr. Cuauthemoc De la PeñaDra. Gabriela Nuñez Guardado Dr. José Hinojosa GómezDr. Mario Alberto Ponce ViverosDra. Nora Patricia Álvarez Águila Dra. Higinia CardenesDr. Gabriel Santiago ConchaDr. Armando Félix LeyvaDra. Gabriela Gómez AhumadaDr. Samuel Rivera RiveraDr. Luis Carlos DurazoDr. Luis Alberto ContrerasDra. Guadalupe Elizabeth Trejo DuránDra. Adriana Alvarado ZermeñoDra. Sandra Ileana Pérez ÁlvarezDr. Miguel Souto del BosqueDra. Aida Mota García
Dr. Javier Ismael Altamirano García Dr. Francisco Javier Lozano Dr. Samuel Rosales Pérez Dr. Federico Maldonado Magos Dr. Mauricio Gamez HaroDra. María de Jesus Gonzalez Blanco Dra. Cindy Sharon Ortiz Arce Dra. Julia A. Sáenz Frías Dr. Alejandro Villalvazo Anaya Dra. Mónika Blake Cerda Dr. Federico Maldonado Magos Dra. Stephanie Verónica Muller GrohmannDra. Daneli Ruiz Sánchez Dra. Regina Pantoja López Dra. Diana Toledano CuevasDr. Armando Fernandez Orozco Dr. Francisco Velasco Canseco Dr. Yael Cázares Ordoñez Dr. Rafael Piñeiro Retif Dra. Amelia Sarricolea Puch Dra. Gerardo Rodriguez AbrajanDr. Antonio Robles Cerda Dr. Jaime Soto Lugo Dr. Jorge Ramiro Corral Beltrán Dr. Manuel Flores Castro Dr. Christian Estrada Hdez.Dr. Erik Pérez
WhatsApp: 999 549 7809
8:45
9:00
9:15
9:30
9:45
10:00
10:20
11:10
11:40
VIERNES 26 DE MARZO
InauguraciónPresidente CMCR, Presidente SOMERA, Comite Cientifico Best Of ASTRO
BREAST CANCER
Abstract 52 De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or not to Boost?"
Abstract 49 Heterogeneity in Outcomes Among Women with Clinically Node-Positive Breast Cancer and Axillary Pathologic Complete Response: An Analysis of NSABP B18, B27, B40, and B41
Abstract 25 Defining the Optimal Dose for 3D-Conformal Accelerated Partial Breast Irradiation (APBI): 10-year Follow Up of a Dose-Escalation Trial Abstract 24 Patient reported experience with treatment modalities and safety of adjuvant breast radiotherapy First results of the randomized HYPOSIB – trial (ARO 2013-05)
Mesa Redonda:
Simposio de la Industria
Coffe Break
SISTEMA NERVIOSO CENTRAL
Abstract 1124 Clinical Value and Optimal Timing of Cranial Local Therapy among EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases in the Era of Osimertinib
Dra. Christian Haydee Flores Balcázar - Jefa de la Unidad de Radio-Oncología del Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
Dra. Karla Elizabeth Ramirez Alday
Dra. Lorena Lio Mondragón - Radio Terapeuta en Hospital Angeles
Dra. Sandra Pérez Álvarez - Especialista en Radio-Oncología en Instituto Nacional de Cancerología
Dra. Nimbe Barroso / Profesora Invitada: Dra. Onix Garay Villar
Dr. Alejandro Solórzano Meléndez - Especialista en Radio-Oncología en Clínica de Radioterapia de Occidente
WhatsApp: 999 549 7809
11:55
12:10
12:25
12:40
13:00
13:15
13:30
VIERNES 26 DE MARZO
Abstract 42 Radiotherapy Dose-Intensification using IMRT versus Standard-Dose Radiotherapy with Temozolomide in Newly Diagnosed Glioblastoma: Preliminary Results of NRG Oncology BN001
Abstract 41 Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial"
Abstract 40 A Phase II Study of Metformin and Neo-adjuvant Temozolomide Followed by HypofractionatedAccelerated Radiotherapy with Concomitant and Adjuvant Metformin and Temozolomide in Patients with Glioblastoma
Mesa Redonda:
GASTRO INTESTINAL
Abstract 3321 SBRT vs TACE in locally advanced hepatocellular carcinoma (HERACLES: HEpatocellular carcinoma stereotactic RAdiotherapy CLinical Efficacy Study)
Abstract 95 Nonoperative management versus surgery in patients with complete endoscopic response to neoadjuvant therapy for rectal cancer
Abstract 175 Serial Circulating Tumor DNA for Evaluating Early Response During Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Analysis of A Prospective Biomarker Study
Dra. Adriana Jimenez Cantero - Especialista en Radio Oncología en Centro Médico ABC
Dr. Luis Héctor Bayardo López - Jefe del Departamento de RadioterapiaUMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente.
Dr. Pedro Rubén León Arceo - Oncólogo Médico, Centro Médico Hidalgo en Monterrey, N.L.
Dr. Cuauhtémoc de la Peña / Profra. Invitada: Dra. Gabriela Nuñez Guardado
Dr. José Hinojosa Gómez - Especialista en Radio Oncología en el Centro Médico ABC
Dr. Mario Ponce Viveros - Radioterapeuta en UMAE Hospital de Oncologia de CMN Siglo XXI
Dr. Mario Ponce Viveros - Radioterapeuta en UMAE Hospital de Oncologia de CMN Siglo XXI
WhatsApp: 999 549 7809
13:45
14:00
14:20
15:00
15:15
15:30
15:45
16:00
VIERNES 26 DE MARZO
Abstract 96 Complete Clinical Response (cCR) Rate in Patients with Rectal Adenocarcinoma Treated with Short-Course RT (SCRT) and Non-Operative Management (NOM) Intent Mesa Redonda:
Lunch Break
GENITO URINARIO
Abstract 55 Bladder Preservation with Twice-Daily Radiation plus 5-Flourouracil/Cisplatin or Daily Radiation plus Gemcitabine for Muscle Invasive Bladder Cancer – Updated Results of NRG/RTOG 0712: A Randomized Phase 2 Trial
Abstract 54 A PHASE II MULTI-CENTRE TRIAL OF STEREOTACTIC RADIOTHERAPY FOR OLIGOPROGRESSION IN METASTATIC KIDNEY CANCER PATIENTS RECEIVING TYROSINE KINASE INHIBITOR THERAPY Abstract 127 An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer Abstract 32 Short-Term Adjuvant versus Neoadjuvant Hormone Therapy in Localized Prostate Cancer: An Individual Patient Meta-Analysis
Mesa Redonda
Dra. Nora Patricia Alvarez Aguila - Radioterapeuta en Instituto Nacional de Cancerología
Dra Nora Patricia Alvarez Aguila / Prof Invitado: Dra Higinia R. Cardenes Perera M.D, PhD ( New York Presbyterian Hospital/ Departament of Radiation Oncology; Weill Cornel Medicine
Dr. Gabriel Santiago Concha - Especialista en Radio Oncología en Centro Médico ABC
Dr. Armando Félix Leyva - Radioterapeuta en Hospital Angeles
Dra. Gabriela Gómez Ahumada
Dr. Samuel Rivera Rivera - Jefe de Departamento de Oncología Médica en UMAE Hospital de Oncología CMN SXXI
Dr. Luis Carlos Durazo / Prof. Invitado: Dr. Luis Alberto Contreras
WhatsApp: 999 549 7809
16:20
16:35
16:50
17:05
17:20
VIERNES 26 DE MARZO
GINECOLÓGICOS
Abstract 234 Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer
bstract 106 Utilizing Immune Profiles to Predict Pelvic Failure in Endometrial Cancer
Abstract 105 Is the Risk of Substantial LVSI in Stage I Endometrial Cancer Similar to PORTEC in the North American Population? - A Single-Institution Study
Abstract 2 Phase III RCT of Postoperative Adjuvant 3DCRT vs. IG-IMRT for reducing Late Bowel Toxicity in Cervical Cancer (PARCER)
Mesa Redonda:
Dra. Guadalupe Elizabeth Trejo Durán - Especialista en Radio Oncología en Centro Médico ABC
Dra. Adriana Alvarado Zermeño - Especialista en Radio Oncología en Clínica de Radioterapia de Occidente
Dra. Sandra Pérez Álvarez - Especialista en Radio-Oncología en Instituto Nacional de Cancerología
Dr. Miguel Souto del Bosque - Especialista en Radio-Oncología en Centro de Cáncer Monterrey
Dra. Aida Mota García / Profra. Invitada: Dra. Higinia R. Cardenes Perera M.D, PhD (New York Presbyterian Hospital/ Departament of Radiation Oncology; Weill Cornel Medicine)
WhatsApp: 999 549 7809
8:30
8:45
9:00
9:15
9:30
9:50
10:40
11:10
11:25
SÁBADO 27 DE MARZO
CABEZA Y CUELLO
Abstract 226 Efficacy and safety of aprepitant for the prevention of nausea and emesis during concurrent chemoradiotherapy in locally advanced head and heck squamous cell carcinoma (LA-HNSCC): A prospective, single-arm, open-label phase 2 trial Abstract 222 Nivolumab and ipilimumab combined with definitive radiation therapy in locally advanced squamous cell carcinoma of the head and neck: in-field toxicity analysis of a phase I clinical trial
Abstract 178 Risk and Predictors of Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors treated with definitive radiotherapy: A Retrospective Cohort Study among 1,988 Survivors
Abstract 179 Development of Advanced Preselection Tools to Reduce Unnecessary Plan Comparisons in Model-based Selection of HNC Patients for Proton Therapy
Mesa Redonda:
Simposio de la INDUSTRIA
Coffe Break
PULMÓN
Abstract LBA 8 Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia
Abstract LBA 3 Patterns of Disease Progression After Carboplatin / Etoposide + Atezolizumab in Extensive-Stage Small Cell Lung Cancer
Dr. Javier Ismael Altamirano García - Radio-Oncólogo en Médica Sur
Dr. Francisco Javier Lozano - Radio-Oncólogo en Médica Sur
Dr. Samuel Rosales Pérez - Jefe de Servicio de Radioterapia en Hospital Ángeles
Dr. Federico Maldonado Magos - Maestro en Ciencias Médicas, especialista en Radio-Oncologia en Centro Médico ABC
Dra. María de Jesús González Blanco / Prof. Invitado: Dr. Mauricio Gamez Haro
Dra. Cindy Sharon Ortiz Arce - Radioterapeuta en Hospital Angeles
Dra. Julia A.Sáenz Frías - Radio Oncólogo en IMSS UMAE 25
WhatsApp: 999 549 7809
11:40
11:55
12:10
12:30
12:45
13:00
13:15
13:30
13:50
SÁBADO 27 DE MARZO
Abstract 1045 Statin Use and Major Adverse Cardiac Events among High Cardiac Risk Patients with Lung Cancer Receiving Radiotherapy
Abstract 1044 Coronary Artery Calcification Burden as a Risk Factor for Cardiac Toxicity in Patients Treated on Radiation Dose-escalation Trials for Stage III Non-small-cell Lung Cancer
Mesa Redonda:
HEMATOLOGÍA
Abstract 1104 Is Bridging Radiation Safe with B cell maturation antigen–targeted chimeric antigenic receptor T cell (CART-BCMA) Therapy? Abstract 1108 Effective Pain Control with Very Low Dose Palliative Radiotherapy for Multiple Myeloma Patients with Painful Osseous Lesions
Abstract 243 Assessing the Role of Radiation Therapy for Primary Mediastinal Large B-Cell Lymphoma in the Setting of PET-Avid Disease after Chemotherapy Abstract 1050 An Absolute Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most?
Mesa Redonda:
CUIDADOS PALIATIVOS
Abstract 185 Safety and efficacy of multi-site stereotactic body radiotherapy and pembrolizumab for patients with large, treatment-refractory tumors
Dr. Alejandro Villalvazo Anaya - Radioterapeuta en IMSS
Dra. Mónika Blake Cerda - Especialista en Radio-Oncología en Centro Médico ABC
Dr. Federico Maldonado Magos
Dra. Stephanie Muller - Especialista en Radio Oncología
Dra. Daneli Ruiz Sánchez - Especialista en Radio-Oncología y Profesor en UANL
Dra. Regina Pantoja López - Especialista en Radio-Oncología en IMSS
Dra. Diana Toledano - Especialista en Radio-Oncología
Dr. Armando Fernandez Orozco Prof. Invitado: Dr. Jose Hinojosa
Dr. Francisco Velasco Canseco - Radio-Oncólogo en el Centro Oncológico de Ciudad Victoria
WhatsApp: 999 549 7809
14:05
14:20
14:35
14:50
15:10
16:00
16:15
16:30
16:45
17:00
17:15
SÁBADO 27 DE MARZO
Abstract LBA 2 A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases (NCT02512965) Abstract 184 Stereotactic Radiation for the Comprehensive Treatment of Oligometastatic Cancers (SABR-COMET) – Long-Term Results
Abstract 182 Phase II clinical trial of stereotactic body radiotherapy for painful non-spine bone metastases
Mesa Redonda:
Lunch Break
FÍSICOS
Abstract 12 FLASH Dose Rate Effect on Circulating Immune Cells: A Potential Mechanism for FLASH-RT?
Abstract 212 Clinical Evaluation of a Deep Learning Model for Segmentation of Nodal Clinical Target Volumes in Breast Cancer Radiotherapy
Abstract 6 Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology that may Benefit from Adjuvant Radiation
Abstract 87 Dual-energy CT Imaging using a Single-energy CT Data via Deep Learning: A Contrast-enhanced CT Study
Mesa Redonda:
Clausura
Dr. Yael Cázares Ordoñez - Radio Oncóloga en IMSS
Dr. Rafael Piñeiro Retif - Jefe del Depto. de Radioterapia en Doctors Hospital
Dra. Amelia Sarricolea Puch - Radio Oncóloga en Oncología Radiante
Dr. Gerardo Rodriguez Abrajan / Prof. Invitado: Dr. Antonio Robles Cerda
Dr. Jaime Soto Lugo - Radioterapeuta en Hospital Christus Muguerza
Dr. Jorge Ramiro Corral Beltrán - Físico Médico en Hospital Christus Muguerza
Dr. Manuel Flores Castro - Radioterapeuta en Médica Sur
Dr. Christian Estrada Hdez. - Físico Médico en Radiophysica
Dr. Erik Pérez / Prof. Invitado: Dr. Manuel Flores Castro
WhatsApp: 999 549 7809
